Summary
E-5166 is a newly synthesized polyprenoic acid that has been reported to control epithelial differentiation and to have antiproliferative effects on various tumor cells in vitro. This study examined the effects of E-5166 on the proliferation of keratinocytes. Three kinds of keratinocytes were used: normal human keratinocytes, a human trichilemmoma-derived K-TL-1 cell line, and a Pam 212 cell line. Cell proliferation was measured by 3H-thymidine incorporation and also by determining cell numbers. E-5166 was found to have significant antiproliferative effects on each of the cell lines studied. When Pam 212 cells were cultured in the presence of E-5166, cell proliferation was inhibited in a dose-dependent fashion. The inhibitory effect appeared to be reversible, since removal of E-5166 from the culture medium resulted in a subsequent return of cell proliferation. For normal human keratinocytes and K-TL-1 cells, E-5166 inhibited 3H-thymidine incorporation in a dose-dependent fashion. Furthermore, E-5166 showed significantly stronger antiproliferative capacity than Ro 10-9359, one of the aromatic retinoids, on Pam 212 cells and normal human keratinocytes.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Conor MJ, Lowe NJ, Breeding JH, Chalet M (1983) Inhibition of ultraviolet-B skin carcinogenesis by all-trans-retinoic acid regimens that inhibit ornithine decarboxylase induction. Cancer Res 43:171–174
Cope FO, Howard BD, Boutwell RK (1986) The in vitro characterization of the inhibition of mouse brain protein kinase-C by retinoids and their receptors. Experimentia 42:1023–1027
Fontana JA (1987) Interaction of retinoids and tamoxifen on the inhibition of human mammary carcinoma cell proliferation. Exp Cell Biol 55:136–144
Fuchs E, Green H (1981) Regulation of terminal differentiation of cultured human keratinocytes by vitamin A. Cell 25:617–625
Haddox MK, Russel DH (1979) Cell cycle-specific locus of vitamin A inhibition of growth. Cancer Res 39:2476–2480
Hoting E, Meissner K (1988) Arotinoid-ethylester. Effectiveness in refractory cutaneous T-cell lymphoma. Cancer 62:1044–1048
Kanzaki T, Eto H, Uezawa A, Maeda T, Iwase H, Ito M (1981) Morphological, biological, and biochemical characteristics of a benign human trichilemmoma cell line in vivo and in vitro. Cancer Res 41:2468–2475
Koji M, Kanzaki T, Mizuno N (1988) Polyprenoic acid is effective to prevent UVB induced skin tumors. Photomed Photobiol 10:225–229
Lowe NJ, Lazarus V, Matt L (1988) Systemic retinoid therapy for psoriasis. J Am Acad Dermatol 19:186–191
Murphy GM, Greaves MW (1988) Acne and psoriasis. Br Med J 296:546–548
Okada N, Ikeda N, Kitano Y, Yoshikawa K (1988) Effect of a new synthetic retinoid (E-5166) on the differentiation of cultured human keratinocytes. Nippon Hifuka Gakkai Zasshi 98:15–20
Spora MB, Dunlop NM, Newton DL, Henderson WR (1976) Relationships between structure and activity of retinoids. Nature 263:110–113
Yuspa SH, Hawley-Nelson P, Koehler B, Stanley JR (1980) A survey of transformation markers in differentiating epidermal cell lines in culture. Cancer Res 40:4694–4703
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Koji, M., Kanzaki, T. & Takashima, A. Polyprenoic acid, E-5166, is effective in inhibiting the proliferation of keratinocytes in vitro. Arch Dermatol Res 282, 135–138 (1990). https://doi.org/10.1007/BF00493473
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00493473